De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

NCT02281955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell
Head and Neck Neoplasms
Oropharyngeal Neoplasms

Interventions

RADIATION: Intensity Modulated Radiotherapy (IMRT)
DRUG: Cisplatin (or alternative)
PROCEDURE: Assessment for surgical evaluation

Sponsor

UNC Lineberger Comprehensive Cancer Center